In this work we aimed to study polymorphisms in LMP1 from pediatric samples because of the particular incidence of Hodgkin lymphoma (HL) in our geographic region, where our group has previously reported a high incidence in children below ten years of age in contrast to what is described in the United States and most European countries where HL shows an incidence peak between 15 and 30 years. This evidence concerns the gene PDLIM7 and Hodgkins lymphoma.